I have been passionately interested in molecular biology, genetics and biotechnological applications since my student days. My current field of research is protein-protein interactions and protein detection. For more than 15 years, my research group has been using phage display to develop peptides that are to be developed into therapies against Alzheimer’s dementia. Other peptides selected by us prevent the interaction between proteins on bacterial pathogens and those on human host cells or the interactions between viral proteins, possibly preventing infectious diseases. We are also investigating biomarkers in connection with various diseases, for example menstrual migraine.

• Protein-protein interactions
• Therapy and diagnosis of neurodegenerative dementia
• Prevention of bacterial or viral infectious diseases
• Biomarker detection and development
• Molecular biology and genetics

Within the university

• Senate Member
• Director of the Institute for Bioanalytics
• Executive Member of the Ethics Commission
• Member of the Analytics4Health Doctoral Center
• Head of the Laboratory of Biochemistry and Molecular Biology
• Officer for the Equality of Women in Science and the Arts – Faculty of Applied Natural Sciences and Health
• Chair of the Arbitration Commission on Performance Bonuses

Outside the university

• Privatdozentin – University of Bayreuth
• Various expert activities

• 2016–2021: Vice President for Research, Coburg University of Applied Sciences and Arts
• 2015: Rehabilitation at the University of Bayreuth
• 2014: Habilitation University of Düsseldorf
• April 2013: Chair of Molecular Biology, Coburg University of Applied Sciences and Arts
• 2007 – 2013: Group leader, Forschungszentrum Jülich GmbH: Therapy and diagnosis of Alzheimer’s dementia
• 2005 – 2007: Postdoc, Institute of Physical Biology, University of Düsseldorf
• 02/2005: Doctorate at the Institute for Molecular Enzyme Technology, University of Düsseldorf
• 1995-2001: Study of Biology, Ruhr-University Bochum